MedPath

Examining the Feasibility of an Online Cognitive Behaviour Therapy (CBT) - based self-management Program for Adults with Neurological Conditions.

Not Applicable
Completed
Conditions
Depression
Executive difficulties
Multiple Sclerosis
Anxiety
Memory difficulties
Epilepsy
Traumatic Brain Injury
Stroke
Mental Health - Anxiety
Mental Health - Depression
Registration Number
ACTRN12617000581369
Lead Sponsor
Dr Milena Gandy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
100
Inclusion Criteria

Confirmed diagnosis of a neurological condition; Multiple Sclerosis, Epilepsy, Parkinson’s Disease, Stroke, Traumatic Brain Injury or Acquired Brain Injury.
- Experiencing cognitive difficulties (e.g., difficulties with memory, attention, planning) that are impacting their day-to-day activities and quality of life
- Want to learn information and skills to limit the impact of their neurological condition on their emotional and cognitive wellbeing.
-Aged 18 years or older.
-Living in Australia.

Exclusion Criteria

- Inability to use a computer.
- Very severe depression (i.e., indicated by a score > 22 on the PHQ-9).
- Significant suicidal ideation (i.e., indicated by a score > 2 to Question 9 of the PHQ-9).
- Acutely suicidal or recent history of attempted suicide or self-harm (i.e., last 12 months).
- Serious cognitive impairment or dementia (<21 on the Telephone Interview of Cognitive Status; TICS).
-Not being under the medical management of a doctor for their neurological condition.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
World Health Organization Disability Assessment Schedule 2.0 12-Item (WHODAS-12). This is a measure that assesses health and disability, which is applicable to a variety of disability domains, including neurological, mental, and chronic physical conditions.[Application, pre-treatment, mid-treatment (5 weeks post commencement), post-treatment (10 weeks post commencement), 3-months post-treatment.];Patient Health Questionnaire 9-Item (PHQ9), which is a measure of depression.[Application, pre-treatment, mid-treatment ( 5 weeks post commencement), post-treatment (10 weeks post commencement), 3-months post-treatment.];Generalized Anxiety Disorder 7-Item (GAD7), which is a measure of anxiety.[Application, pre-treatment, mid-treatment (5 weeks post commencement), post-treatment (10 weeks post commencement), 3-months post-treatment.]
Secondary Outcome Measures
NameTimeMethod
Perceived Deficits Questionnaire (PDQ), which is a measure of cognitive difficulties. [Pre-treatment, mid-treatment (post-commencement), post-treatment (10 weeks post commencement), 3-months post-treatment.];Fatigue Severity Scale (FSS), which is a measure of the severity of fatigue.[Pre-treatment, mid-treatment (5 weeks post commencement) post-treatment (10 weeks post commencement), 3 month post-treatment.];Treatment Satisfaction Questionnaire (TSQ), which is a purpose built measure to assess the acceptability of online treatment Courses and to measure participants’ satisfaction with treatment.[Post-treatment (10 weeks post commencement)]
© Copyright 2025. All Rights Reserved by MedPath